StockTipsArenaBeta

BUY Piramal Pharma Limited — Vishnu Kant Upadhyay, Master Capital Services

BUYPiramal Pharma Limited
Piramal Pharma share price target & all analyst calls

byVishnu Kant Upadhyay, Master Capital ServicesHorizon: NA (inferred Swing (≤2wk))21 Jul 2026via Business Today

Entry₹184.81Inferred
Target₹220
Total upside +19.04% (call closed)
Stop loss₹173-6.39% risk
At expiry₹202.144 Aug 2026, 3:30 pm
Expired+9.38%
Follow Vishnu Kant Upadhyay for new calls(13% target hit, 99 closed calls)Get alertsWatch PPLPHARMA for new buy/sell callsGet alertsSee 135 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 4 Aug 2026
11 supporting4 neutral3 opposing
Supports the BUY call (11)

Piramal Pharma Limited Expands Peptide API Facility with Advanced Spray Drying Suite

NewsGoogle News·4 Aug · today

(opens in new tab)

Piramal Pharma Restarts Operations At Ahmedabad Units After Flood Interruption

NewsGoogle News·3 Aug · today

(opens in new tab)

Piramal Pharma Limited (NSE:PPLPHARMA) Just Reported And Analysts Have Been Lifting Their Price Targets

NewsGoogle News·3 Aug · yesterday

(opens in new tab)

2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·3 Aug · yesterday

Piramal Pharma narrows Q1 loss as revenue jumps 17%, EBITDA nearly doubles

NewsCnbc-Tv18·29 Jul · 5d ago

(opens in new tab)
Neutral / worth noting (4)

Buy, Sell Or Hold: Mahindra & Mahindra, UltraTech Cement, Piramal Pharma, Groww And Swiggy — Ask Profit

NewsNdtv-Profit·30 Jul · 4d ago

(opens in new tab)

Piramal Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·29 Jul · 5d ago

(opens in new tab)

Piramal Pharma temporarily suspends Ahmedabad plant operations due to heavy rainfall

NewsCnbc-Tv18·25 Jul · 1w ago

(opens in new tab)

Piramal Pharma, Authum Investment, Vaibhav Global Show Technical Breakouts

NewsGoogle News·20 Jul · 2w ago

(opens in new tab)
Weighs against the BUY call (3)

HDFC Mutual Fund reduces stake in Piramal Pharma by 2.005%

NewsGoogle News·18 Jul · 2w ago

(opens in new tab)

HDFC Mutual Fund Sells 2% Stake in Piramal Pharma

NewsGoogle News·17 Jul · 3w ago

(opens in new tab)

HDFC Mutual Fund ने Piramal Pharma मधील हिस्सा विकला, मोठी घट!

NewsGoogle News·17 Jul · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Piramal Pharma

All analyst calls on Piramal Pharma

More from Vishnu Kant Upadhyay, Master Capital Services

Every call and its outcome